Evidence map›Paper›PMID 25467444›Full record

ArticleCell2014

Proteostatic control of telomerase function through TRiC-mediated folding of TCAB1.

Adam Freund, Franklin L Zhong, Andrew S Venteicher, Zhaojing Meng, Timothy D Veenstra, Judith Frydman, Steven E Artandi

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biogenesis and Regulation of Telomerase during Development and Cancer.Cold Spring Harbor perspectives in biology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Science advances · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. circHERC1-A telomerase activator.Science advances · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adam FreundDepartment of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Franklin L ZhongCancer Biology Program, Stanford University School of Medicine, Stanford, CA 94305, USA.
Andrew S VenteicherDepartment of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Zhaojing MengLaboratory of Proteomics and Analytical Technologies, Science Applications International Corporation-Frederick, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Timothy D VeenstraLaboratory of Proteomics and Analytical Technologies, Science Applications International Corporation-Frederick, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Judith FrydmanDepartment of Biology, Stanford University, Stanford, CA 94305, USA.
Steven E ArtandiDepartment of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Cancer Biology Program, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: sartandi@stanford.edu.
Stanford University · USNational Cancer Institute · US

Funding

Wnt signaling in muscle stem cell agingP01AG036695 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARGARET A. GOODELL · 2011 to 2026
$29.3M
Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Protein Folding in the Eukaryotic CytosolR37GM056433 · NIGMS · STANFORD UNIVERSITY · PI FRYDMAN, JUDITH · 2013 to 2022
$4.6M
Telomeres, Telomerase and Tumor ProgressionR01CA111691 · NCI · STANFORD UNIVERSITY · PI ARTANDI, STEVEN E · 2005 to 2015
$2.8M
Regulation of the Telomerase Protein Component In CancerR01CA125453 · NCI · STANFORD UNIVERSITY · PI ARTANDI, STEVEN E · 2006 to 2015
$2.2M
Defining the telomerase holoenzyme in progenitor cells with agingR01AG033747 · NIA · STANFORD UNIVERSITY · PI ARTANDI, STEVEN E · 2010 to 2014
$1.6M
Defining the telomerase holoenzyme in progenitor cells with agingR56AG033747 · NIA · STANFORD UNIVERSITY · PI ARTANDI, STEVEN E · 2016 to 2016
$597k
Upgraded High-Content and High-Throughput siRNA Screening SystemS10RR026338 · NCRR · STANFORD UNIVERSITY · PI SOLOW-CORDERO, DAVID EDWARD · 2010 to 2010
$498k
NCI NIH HHS CA111691NCI NIH HHS CA125453NCI NIH HHS R01 CA111691NCI NIH HHS R01 CA125453NCI NIH HHS T32 CA009302NCI NIH HHS T32CA09302NCRR NIH HHS S10 RR026338NCRR NIH HHS S10RR026338NIA NIH HHS AG033747NIA NIH HHS AG036695NIA NIH HHS P01 AG036695NIA NIH HHS R01 AG033747NIA NIH HHS R56 AG033747NIGMS NIH HHS R37 GM056433
6 · The paper itself

Abstract

Telomere maintenance by telomerase is impaired in the stem cell disease dyskeratosis congenita and during human aging. Telomerase depends upon a complex pathway for enzyme assembly, localization in Cajal bodies, and association with telomeres. Here, we identify the chaperonin CCT/TRiC as a critical regulator of telomerase trafficking using a high-content genome-wide siRNA screen in human cells for factors required for Cajal body localization. We find that TRiC is required for folding the telomerase cofactor TCAB1, which controls trafficking of telomerase and small Cajal body RNAs (scaRNAs). Depletion of TRiC causes loss of TCAB1 protein, mislocalization of telomerase and scaRNAs to nucleoli, and failure of telomere elongation. DC patient-derived mutations in TCAB1 impair folding by TRiC, disrupting telomerase function and leading to severe disease. Our findings establish a critical role for TRiC-mediated protein folding in the telomerase pathway and link proteostasis, telomere maintenance, and human disease.

Indexed as

Chaperonin Containing TCP-1Dyskeratosis CongenitaHumansIn Situ Hybridization, FluorescenceMolecular ChaperonesProtein FoldingTelomeraseTelomereChaperonin Containing TCP-1Molecular ChaperonesTelomeraseWRAP53 protein, human

Identifiers

PMID25467444
PMCPMC4329143
OpenAlexW2003731662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.